The growing geriatric population, increasing number of hospitals in emerging markets, high prevalence of chronic diseases, and increasing demand for vaccines are the major factors driving the growth of the needles market across the globe.
Download FREE Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223979930
The global needles market is projected to reach $8.47 Billion by 2022 from $5.82 Billion in 2017, at a CAGR of 7.8% during the forecast period.
This report broadly segments the needles market into type, products, material, delivery mode, and end user.
Geographically, emerging Asian countries offer high-growth opportunities for market players. As of 2017. The conducive regulatory policies for the approval of new injectables and rapid growth in the geriatric population are key factors influencing the growth of the Asia-Pacific needles market.
A majority of the leading players, including Medtronic plc (Ireland), Ethicon US, LLC. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), and Boston Scientific Corporation (U.S.), among others in the needles market are developing advanced needles enabled with safety features to secure their position in the market.
To Know More @
https://www.marketsandmarkets.com/Market-Reports/needles-market-223979930.html
